Paul Campbell
Comptroller/Controller/Auditor bei VIATRIS INC.
Vermögen: 2 Mio $ am 30.04.2024
Aktive Positionen von Paul Campbell
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VIATRIS INC. | Comptroller/Controller/Auditor | 16.11.2020 | - |
Karriereverlauf von Paul Campbell
Ehemalige bekannte Positionen von Paul Campbell
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Comptroller/Controller/Auditor | - | - |
Finanzdirektor/CFO | - | - |
Statistik
International
Vereinigtes Königreich | 2 |
Vereinigte Staaten | 2 |
Operativ
Comptroller/Controller/Auditor | 2 |
Director of Finance/CFO | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
VIATRIS INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Paul Campbell
- Erfahrung